XBiotech (XBIT) Share-based Compensation (2014 - 2025)
XBiotech (XBIT) reported Share-based Compensation of $162,000 for Q4 2025, down 74.2% from $628,000 a year earlier but up 575.0% from the prior quarter.
Powered by 
Analysis
XBiotech (XBIT) Share-based Compensation (2014 - 2025) Analysis & Trends
For FY2025, XBiotech posted Share-based Compensation of $3.62 million, up 106.6% from FY2024.
- Share-based Compensation has a five-year compound annual growth rate of -22.0% (FY2020 to FY2025).
- By year, Share-based Compensation came in at $1.75 million in FY2024 (-46.3%), $3.26 million in FY2023 (-35.6%), $5.06 million in FY2022 (+13.4%) and $4.46 million in FY2021 (-64.5%).
- Five-year quarterly Share-based Compensation spans a low of $24,000 in Q3 2025 and a high of $3.33 million in Q1 2025.
- Year over year, Share-based Compensation has now declined in each of the last three quarters, with growth averaging 44.9% over the last eight quarters.
- The high point for year-over-year Share-based Compensation in five years was Q1 2025 (growth of 773.8%); the low point was Q3 2025 (a decline of 93.4%).
- Per Business Quant data, the three quarters before Q4 2025 came in at $24,000 (Q3 2025), $107,000 (Q2 2025) and $3.33 million (Q1 2025).
Peer Set
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Stock Comp. (Qtr) |
|---|---|---|---|---|---|
| 1 | Johnson & Johnson | 655.56 Bn | 574.09 Bn | 17.26 Bn | 458.00 Mn |
| 2 | AbbVie | 470.94 Bn | 444.10 Bn | 12.70 Bn | 166.00 Mn |
| 3 | Merck | 367.14 Bn | 321.57 Bn | 12.21 Bn | 298.00 Mn |
| 4 | Novartis Ag | 280.33 Bn | 236.20 Bn | 11.24 Bn | - |
| 5 | Astrazeneca | 257.78 Bn | 231.34 Bn | 12.86 Bn | - |
| 6 | Amgen | 226.04 Bn | 181.44 Bn | 7.24 Bn | 165.00 Mn |
| 7 | Gilead Sciences | 188.89 Bn | 163.01 Bn | 6.22 Bn | 231.00 Mn |
| 8 | Pfizer | 163.75 Bn | 110.70 Bn | 10.94 Bn | 249.00 Mn |
| 9 | Vertex Pharmaceuticals | 133.68 Bn | 105.69 Bn | 2.84 Bn | 170.20 Mn |
| 10 | XBiotech | 65.55 Mn | 65.55 Mn | - | - |
Historic Data
Download Data
Historic Data
| Date | Value |
|---|---|
| Dec 31, 2025 | 162,000.00 |
| Sep 30, 2025 | 24,000.00 |
| Jun 30, 2025 | 107,000.00 |
| Mar 31, 2025 | 3.33 Mn |
| Dec 31, 2024 | 628,000.00 |
| Sep 30, 2024 | 365,000.00 |
| Jun 30, 2024 | 379,000.00 |
| Mar 31, 2024 | 381,000.00 |
| Dec 31, 2023 | 688,000.00 |
| Sep 30, 2023 | 955,000.00 |
| Jun 30, 2023 | 914,000.00 |
| Mar 31, 2023 | 705,000.00 |
| Dec 31, 2022 | 1.04 Mn |
| Sep 30, 2022 | 1.13 Mn |
| Jun 30, 2022 | 1.45 Mn |
| Mar 31, 2022 | 1.45 Mn |
| Dec 31, 2021 | 1.35 Mn |
| Sep 30, 2021 | 1.13 Mn |
| Jun 30, 2021 | 1.04 Mn |
| Mar 31, 2021 | 936,000.00 |
API Access
XBiotech Share-based Compensation API
Pull this series into your own models, spreadsheets and apps with the Business Quant
Historical Metrics API. The request below matches the chart above — change the
frequency, period or values and it follows. Swap YOUR_API_KEY for your own key.
https://data.businessquant.com/historic?slug=share-based-compensation&ticker=XBIT&period=max&api_key=YOUR_API_KEYimport requests
url = "https://data.businessquant.com/historic"
params = {"slug": "share-based-compensation", "ticker": "XBIT", "period": "max", "api_key": "YOUR_API_KEY"}
data = requests.get(url, params=params).json()const res = await fetch("https://data.businessquant.com/historic?slug=share-based-compensation&ticker=XBIT&period=max&api_key=YOUR_API_KEY");
const data = await res.json();